|
Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk reuters.comF.D.A. Approves New Weight-Loss Pill The New York TimesFDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market CNBCAnother GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it's used CNN
|
|
Nike has shown some gains in North America, its largest market, amid its turnaround, but the strength was offset by weakness in China.
|
|
Chris O'Neill, CEO of GrowthLoop, joins Barbara and Americus to explore how compound marketing, agentic AI, and data-driven experimentation are redefining marketing workflows and customer experiences, using his insights from decades of leadership across technology, data, and brand-driven growth. Hosted on Acast. See acast.com/privacy for more information.
|
|
